JP2019521659A5 - - Google Patents

Download PDF

Info

Publication number
JP2019521659A5
JP2019521659A5 JP2018561967A JP2018561967A JP2019521659A5 JP 2019521659 A5 JP2019521659 A5 JP 2019521659A5 JP 2018561967 A JP2018561967 A JP 2018561967A JP 2018561967 A JP2018561967 A JP 2018561967A JP 2019521659 A5 JP2019521659 A5 JP 2019521659A5
Authority
JP
Japan
Prior art keywords
genome editing
editing complex
complex according
peptide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018561967A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019521659A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/034862 external-priority patent/WO2017205846A1/en
Publication of JP2019521659A publication Critical patent/JP2019521659A/ja
Publication of JP2019521659A5 publication Critical patent/JP2019521659A5/ja
Priority to JP2021184056A priority Critical patent/JP7379447B2/ja
Priority to JP2023169638A priority patent/JP2023165986A/ja
Priority to JP2025079827A priority patent/JP2025118829A/ja
Pending legal-status Critical Current

Links

JP2018561967A 2016-05-27 2017-05-26 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子 Pending JP2019521659A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021184056A JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2023169638A JP2023165986A (ja) 2016-05-27 2023-09-29 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2025079827A JP2025118829A (ja) 2016-05-27 2025-05-12 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662342823P 2016-05-27 2016-05-27
US62/342,823 2016-05-27
US201662394140P 2016-09-13 2016-09-13
US62/394,140 2016-09-13
US201762477357P 2017-03-27 2017-03-27
US62/477,357 2017-03-27
PCT/US2017/034862 WO2017205846A1 (en) 2016-05-27 2017-05-26 Peptides and nanoparticles for intracellular delivery of genome-editing molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021184056A Division JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Publications (2)

Publication Number Publication Date
JP2019521659A JP2019521659A (ja) 2019-08-08
JP2019521659A5 true JP2019521659A5 (https=) 2020-07-02

Family

ID=59239942

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018561967A Pending JP2019521659A (ja) 2016-05-27 2017-05-26 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2021184056A Active JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2023169638A Withdrawn JP2023165986A (ja) 2016-05-27 2023-09-29 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2025079827A Pending JP2025118829A (ja) 2016-05-27 2025-05-12 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021184056A Active JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2023169638A Withdrawn JP2023165986A (ja) 2016-05-27 2023-09-29 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2025079827A Pending JP2025118829A (ja) 2016-05-27 2025-05-12 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Country Status (9)

Country Link
EP (2) EP3910059A1 (https=)
JP (4) JP2019521659A (https=)
CN (2) CN109689677B (https=)
AU (2) AU2017268842B2 (https=)
CA (1) CA3025523A1 (https=)
ES (1) ES2901215T3 (https=)
MX (2) MX388294B (https=)
WO (1) WO2017205846A1 (https=)
ZA (1) ZA201807869B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018313940A1 (en) * 2017-08-10 2020-03-05 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of virus
AU2018352221B2 (en) * 2017-10-16 2024-04-18 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of mRNA
FR3081169B1 (fr) * 2018-05-15 2020-06-19 Messenger Biopharma Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
WO2019237387A1 (zh) * 2018-06-16 2019-12-19 深圳市博奥康生物科技有限公司 用于敲除人ACT35基因的gRNA序列及其应用
WO2019237384A1 (zh) * 2018-06-16 2019-12-19 深圳市博奥康生物科技有限公司 用于敲除人CDw137基因的gRNA序列及其应用
CN111363013B (zh) * 2018-12-25 2021-11-19 深圳先进技术研究院 多组分纳米颗粒簇的构建方法
BR112021013173A2 (pt) * 2019-01-04 2021-09-28 The University Of Chicago Sistemas e métodos para modular rna
GB201902648D0 (en) 2019-02-27 2019-04-10 Cyca Oncosolutions Ltd Cell membrane penetrating conjugates
EP3955967A4 (en) 2019-04-17 2023-06-07 Aadigen, LLC PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
CN109880891B (zh) * 2019-04-22 2021-07-30 上海交通大学 基于核酸酶偶联pcr原理富集低丰度dna突变的检测技术体系及应用
CN120022385A (zh) * 2019-05-07 2025-05-23 洛桑联邦理工学院 Fmrp及癌症治疗
CN110638789A (zh) * 2019-10-31 2020-01-03 南开大学 一种可实现肿瘤靶向递送核糖核蛋白复合物的纳米粒子的制备方法和应用
US20230167437A1 (en) * 2020-04-24 2023-06-01 Aadigen, Llc Compositions for treating cancer with kras mutations and uses thereof
WO2022020782A1 (en) * 2020-07-24 2022-01-27 Aadigen, Llc Compositions and methods for treating viral infections
KR102500873B1 (ko) * 2021-02-03 2023-02-17 한국과학기술연구원 자연살해세포 특이적 CRISPR/Cas 시스템을 위한 융합 단백질 및 이의 용도
EP4377472A2 (en) * 2021-07-26 2024-06-05 Imperial College Innovations Limited Nanozyme-catalysed detection of nucleic acids
WO2025059215A1 (en) 2023-09-12 2025-03-20 Aadigen, Llc Methods and compositions for treating or preventing cancer
WO2025090926A1 (en) * 2023-10-26 2025-05-01 The Penn State Research Foundation Ultrasound-sensitive peptide particles with surface-bound gene editing tools for spatially resolved molecule delivery
CN119119204B (zh) * 2024-11-11 2025-03-18 南昌大学 温敏特异性多肽和基于温差特异性无损分离外泌体的方法

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5487994A (en) 1992-04-03 1996-01-30 The Johns Hopkins University Insertion and deletion mutants of FokI restriction endonuclease
US5356802A (en) 1992-04-03 1994-10-18 The Johns Hopkins University Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
US5436150A (en) 1992-04-03 1995-07-25 The Johns Hopkins University Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
AU5600194A (en) 1992-11-13 1994-06-08 Winalee G. Mitchell Absorbent including super absorbent and capacity monitor
EP0832269A1 (en) 1995-06-07 1998-04-01 Baylor College Of Medicine Nucleic acid transporters for delivery of nucleic acids into a cell
WO1997034634A1 (en) 1996-03-20 1997-09-25 Sloan-Kettering Institute For Cancer Research Single chain fv constructs of anti-ganglioside gd2 antibodies
EP1109921A4 (en) 1998-09-04 2002-08-28 Sloan Kettering Inst Cancer FUSION RECEPTORS SPECIFIC TO MEMBRANE SPECIFIC PROSTATIC ANTIGEN AND USES THEREOF
US6410319B1 (en) 1998-10-20 2002-06-25 City Of Hope CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
AU776576B2 (en) 1999-12-06 2004-09-16 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6689558B2 (en) 2000-02-08 2004-02-10 Sangamo Biosciences, Inc. Cells for drug discovery
US20020131960A1 (en) 2000-06-02 2002-09-19 Michel Sadelain Artificial antigen presenting cells and methods of use thereof
ATE338124T1 (de) 2000-11-07 2006-09-15 Hope City Cd19-spezifische umgezielte immunzellen
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7070995B2 (en) 2001-04-11 2006-07-04 City Of Hope CE7-specific redirected immune cells
US20090257994A1 (en) 2001-04-30 2009-10-15 City Of Hope Chimeric immunoreceptor useful in treating human cancers
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US20050129671A1 (en) 2003-03-11 2005-06-16 City Of Hope Mammalian antigen-presenting T cells and bi-specific T cells
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
AU2005232665B2 (en) 2004-04-08 2010-05-13 Sangamo Therapeutics, Inc. Methods and compositions for treating neuropathic and neurodegenerative conditions
US7253273B2 (en) 2004-04-08 2007-08-07 Sangamo Biosciences, Inc. Treatment of neuropathic pain with zinc finger proteins
US7514530B2 (en) 2004-04-26 2009-04-07 Centre National De La Recherche Scientifique Peptide carrier for delivering siRNA into mammalian cells
US7579318B2 (en) 2005-12-06 2009-08-25 Centre De La Recherche De La Scientifique Cell penetrating peptides for intracellular delivery of molecules
SI2856876T1 (en) 2007-03-30 2018-04-30 Memorial Sloan-Kettering Cancer Center Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
US8479118B2 (en) 2007-12-10 2013-07-02 Microsoft Corporation Switching search providers within a browser search box
JP5173594B2 (ja) 2008-05-27 2013-04-03 キヤノン株式会社 管理装置、画像形成装置及びそれらの処理方法
DE102008036364A1 (de) 2008-08-05 2010-02-18 Khs Ag Verfahren zum Herstellen von Behälterzellen
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
US8586526B2 (en) 2010-05-17 2013-11-19 Sangamo Biosciences, Inc. DNA-binding proteins and uses thereof
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
US9987308B2 (en) 2011-03-23 2018-06-05 Fred Hutchinson Cancer Research Center Method and compositions for cellular immunotherapy
WO2012137036A1 (en) 2011-04-04 2012-10-11 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
US8398282B2 (en) 2011-05-12 2013-03-19 Delphi Technologies, Inc. Vehicle front lighting assembly and systems having a variable tint electrowetting element
CN104080797A (zh) 2011-11-11 2014-10-01 弗雷德哈钦森癌症研究中心 针对癌症的靶向细胞周期蛋白a1的t细胞免疫疗法
CA2861491C (en) 2012-02-13 2020-08-25 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Bispecific chimeric antigen receptors and therapeutic uses thereof
WO2013126726A1 (en) 2012-02-22 2013-08-29 The Trustees Of The University Of Pennsylvania Double transgenic t cells comprising a car and a tcr and their methods of use
EP2844743B1 (en) 2012-05-03 2021-01-13 Fred Hutchinson Cancer Research Center Enhanced affinity t cell receptors and methods for making the same
AU2013266968B2 (en) * 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
BR122020002986A8 (pt) 2012-08-20 2023-04-18 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Método e composições para imunoterapia celular
MX370148B (es) 2012-10-02 2019-12-03 Memorial Sloan Kettering Cancer Center Composiciones y su uso para inmunoterapia.
WO2014053880A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053881A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053882A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053879A1 (en) * 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
AU2013335451C1 (en) * 2012-10-23 2024-07-04 Toolgen Incorporated Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof
CN120574876A (zh) 2013-08-22 2025-09-02 纳幕尔杜邦公司 使用向导rna/cas内切核酸酶系统的植物基因组修饰及其使用方法
US9526784B2 (en) * 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US20160304893A1 (en) * 2013-12-13 2016-10-20 Cellectis Cas9 nuclease platform for microalgae genome engineering
JP6823593B2 (ja) * 2014-11-06 2021-02-03 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ Ｒｎａ誘導型エンドヌクレアーゼの細胞へのペプチド媒介輸送
MX387665B (es) 2014-12-24 2025-03-18 Aadigen Llc Péptidos, complejos, moléculas de carga y nanopartículas que contienen los mismos.

Similar Documents

Publication Publication Date Title
JP2019521659A5 (https=)
ES2743188T3 (es) Péptidos y nanopartículas para el suministro intracelular de moléculas
US20200095605A1 (en) Compositions and methods for nucleic acid and/or protein payload delivery
US10377998B2 (en) CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymes
JP6707133B2 (ja) 操作された核酸標的化核酸
US20230323401A1 (en) Methods and compositions for genome editing
JP7471289B2 (ja) 抗ｌｉｖ１免疫細胞癌療法
Lin et al. Chemical evolution of amphiphilic xenopeptides for potentiated Cas9 ribonucleoprotein delivery
US20250101425A1 (en) Nanoparticles functionalized with gene editing tools and related methods
JP2024122981A (ja) ゲノム編集方法及び組成物
CA3181170A1 (en) Compositions for treating cancer with kras mutations and uses thereof
WO2020223705A2 (en) Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
JP2026500040A (ja) 複合体及びその使用
JP2025518552A (ja) 細胞を操作するための組成物及び方法
Futami et al. Design of cytotoxic ribonucleases by cationization to enhance intracellular protein delivery
US12584145B2 (en) Conjugate systems and methods of use thereof
WO2025261493A1 (zh) 通过表观编辑靶向调节pcsk9的方法及其用途
JP2023538138A (ja) ナノ粒子種基材のための組成物及び方法